Repligen Corporation Announces Third Quarter 2025 Financial Results
Repligen Corporation (NASDAQ: RGEN) has made an exciting announcement regarding their upcoming financial results. The company will share its third-quarter financial results on October 28, 2025. As a valued partner in the life sciences sector, this marks a significant moment for Repligen and its stakeholders.
Details on the Upcoming Conference Call
The financial results will be accompanied by a conference call scheduled for 8:30 a.m. ET on the release date. This call will provide insights into the company's financial performance for the three and nine-month periods concluded on September 30, 2025. Repligen encourages everyone to participate in the call and gain further understanding of their business direction.
Accessing the Conference Call
Participants can easily access the conference call through toll-free numbers. Domestic callers can dial (800) 715-9871, while international participants can reach out at (646) 307-1963. Fortunately, there is no need for a passcode during the live call.
What to Expect from Repligen's Financial Results
The preparation of their third-quarter results reflects the company’s ongoing commitment to transparency and engagement with investors. Besides reporting financial performance, Repligen aims to discuss relevant business updates that may impact future operations.
About Repligen Corporation
Repligen Corporation is recognized as a leader in the global life sciences industry. Focused on developing innovative bioprocessing technologies, the company enhances the efficacy and efficiencies in the manufacturing of biological drugs. Repligen’s mission is to inspire advancements in bioprocessing for biopharmaceutical developers and contract development manufacturing organizations (CDMOs) worldwide.
Key Focus Areas
Repligen specializes in several key areas, including Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins. The company operates out of its headquarters in Waltham, Massachusetts, with multiple manufacturing sites located throughout the U.S. and in countries such as Estonia, France, Germany, Ireland, the Netherlands, and Sweden. This extensive infrastructure ensures Repligen is well-positioned to support a growing global demand for bioprocessing innovations.
Staying Informed on Repligen
For stakeholders interested in the latest company developments, Repligen's financial results offer an opportunity to learn more about its strategic direction and growth potential. Interested individuals can visit Repligen's official website for further updates and news regarding the company.
Contact Information
For more inquiries, reach out to Jacob Johnson, VP of Investor Relations, by calling (781) 419-0204 or via email at investors@repligen.com. Repligen is committed to maintaining open lines of communication with its investors and the public.
Frequently Asked Questions
When will Repligen release its third-quarter financial results?
Repligen will report its third-quarter financial results on October 28, 2025.
What time is the conference call for the financial results?
The conference call will take place at 8:30 a.m. ET on the same day.
How can I access the conference call?
Participants can dial (800) 715-9871 for domestic calls or (646) 307-1963 for international calls. No passcode is required.
Where can I find more information about Repligen Corporation?
More information can be found on Repligen's official website.
Who can I contact for investor relations inquiries?
You can contact Jacob Johnson, VP of Investor Relations, at (781) 419-0204 or via email at investors@repligen.com.
